Vaccine (and other biologic) manufacturing services for infectious diseases
Award Notice Posted
- Solicitation number
- 75N98026D00088
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to BCG Federal Corp.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N98026D00088 Federal IDV award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Washington, District of Columbia, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health under the Department of Health and Human Services, awarded contract 75N98026D00088 to BCG Federal Corp. on September 30, 2026, for vaccine and other biologic manufacturing services for infectious diseases.
The IDIQ carries a $10,000 guaranteed minimum and a $48 million ceiling. The award was made under no set-aside.
Notice text
IDIQ Guaranteed Minimum Awarded in the amount of $10,000.
Awarded contract 75N98026D00088 to BCG FEDERAL CORP. for 48000000.00 on 2026-09-30.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Vaccine (and other biologic) manufacturing services for infectious diseases | Award Notice | |
| Vaccine (and other biologic) manufacturing services for infectious diseases | Award Notice | |
| Vaccine (and other biologic) manufacturing services for infectious diseases | Award Notice | |
| This notice | Award Notice | |
| Vaccine (and other biologic) manufacturing services for infectious diseases | Solicitation | |
| Vaccine (and Other Biologic) Manufacturing Services for Infectious Diseases | Pre-Solicitation | |
| Vaccine (and Other Biologic) Manufacturing Services for Infectious Diseases | Pre-Solicitation |
7 of 9 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity